Rosuvastatin prevents the development of hepatocellular carcinoma in mice with nonalcoholic fatty liver disease

被引：0
|
作者：
Yokohama, Keisuke [2 ]
Fukunishi, Shinya [1 ]
Asai, Akira [1 ]
Tsuda, Yasuhiro [1 ]
Higuchi, Kazuhide [1 ]
机构：
[1] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka, Japan
[2] Hokusetsu Gen Hosp, Dept Gastroenterol, Osaka, Japan
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1590
引用
收藏
页码：789A / 789A
页数：1
相关论文
共 50 条
  • [31] From Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: A Systems Understanding
    Damjana Rozman
    [J]. Digestive Diseases and Sciences, 2014, 59 : 238 - 241
  • [32] Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
    Yoshihiro Mikuriya
    Hirotaka Tashiro
    Tsuyoshi Kobayashi
    Shintaro Kuroda
    Tomoyuki Abe
    Masakazu Hashimoto
    Hideki Ohdan
    [J]. Langenbeck's Archives of Surgery, 2015, 400 : 471 - 476
  • [33] Role of rare pathogenic mutations in the development of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
    Pelusi, S.
    Pietrelli, A.
    Baselli, G. A.
    Dongiovanni, P.
    Meroni, M.
    Donati, B.
    Fracanzani, A. L.
    Romagnoli, R.
    Petta, S.
    Miele, L.
    Grieco, A.
    Bugianesi, E.
    Soardo, G.
    De Francesco, R.
    Fargion, S.
    Valenti, L.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S330 - S330
  • [34] Nonalcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma: How common?
    Mittal S.
    White D.L.
    Kanwal F.
    Sussman N.
    El-Serag H.B.
    [J]. Current Hepatology Reports, 2015, 14 (2) : 87 - 98
  • [35] Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Azuma, Seishin
    Asahina, Yasuhiro
    Kakinuma, Sei
    Azuma, Keiko
    Miyoshi, Masato
    Inoue, Emi
    Tsunoda, Tomoyuki
    Sato, Ayako
    Kaneko, Shun
    Nagata, Hiroko
    Kawai-Kitahata, Fukiko
    Murakawa, Miyako
    Nitta, Sayuri
    Itsui, Yasuhiro
    Tomita, Makoto
    Nakagawa, Mina
    Watanabe, Mamoru
    [J]. DIGESTIVE DISEASES, 2019, 37 (03) : 247 - 254
  • [36] Role of rare pathogenic mutations in the development of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease
    Pelusi, S.
    Baselli, G.
    Pietrelli, A.
    Dongiovanni, P.
    Meroni, M.
    Donati, B.
    Fracanzani, A. L.
    Romagnoli, R.
    Petta, S.
    Miele, L.
    Grieco, A.
    Bugianesi, E.
    Soardo, G.
    De Francesco, R.
    Fargion, S.
    Valenti, L.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 28 - 28
  • [37] Functional characterization of a novel genetic variant predisposing to hepatocellular carcinoma development in nonalcoholic fatty liver disease
    Baselli, G. A.
    Longo, M.
    Meroni, M.
    Pelusi, S.
    Fracanzani, A. L.
    Soardo, G.
    Bugianesi, E.
    Romagnoli, R.
    Petta, S.
    Miele, L.
    De Francesco, R.
    Fargion, S.
    Dongiovanni, P.
    Valenti, L.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 16 - 16
  • [38] Serum Biomarkers of Iron Status and Risk of Hepatocellular Carcinoma Development in Patients with Nonalcoholic Fatty Liver Disease
    Yu, Yi-Chuan
    Luu, Hung N.
    Wang, Renwei
    Thomas, Claire E.
    Glynn, Nancy W.
    Youk, Ada O.
    Behari, Jaideep
    Yuan, Jian-Min
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01) : 230 - 235
  • [39] Platelets inhibit hepatocellular carcinoma growth in the context of nonalcoholic fatty liver disease
    McVey, John C.
    Ma, Chi
    Diggs, Laurence
    Fu, Qiong
    Greten, Tim F.
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [40] Epidemiological trends of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease in Italy
    Farinati, F.
    Vitale, A.
    Ortolani, A.
    Miele, L.
    Morales, R. Ramirez
    Trevisani, F.
    Baroni, G. Svegliati
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 : E49 - E49
12345